Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HTR5A antisense RNA 1 (HTR5A-AS1), also known as HTR5AOS or HTR5A opposite strand, is a long non-coding RNA (lncRNA) gene associated with the human genome and is transcribed from the opposite strand of the HTR5A gene. HTR5A antisense RNA 1 is a long non-coding RNA transcribed from the region antisense to the HTR5A gene on chromosome 7 (Chr7:155067034-155072450, hg38). While it does not encode a protein, it is classified as an antisense RNA and part of the broader family of lncRNAs. Antisense RNAs including HTR5A-AS1 typically regulate the expression of their corresponding sense gene through diverse mechanisms, such as chromatin remodeling, transcriptional interference, or post-transcriptional regulation. Although the precise functional characterization of HTR5A-AS1 is limited in current literature, its association with lncRNA functions suggests a role in regulating nearby gene(s), possibly including HTR5A, which encodes a serotonin receptor implicated in neuropsychiatric processes. Diseases associated with HTR5A-AS1 include Autism Spectrum Disorder. General evidence from studies on antisense lncRNAs indicates a broader potential for involvement in cancer and other regulatory disease processes, but such associations remain to be specifically defined for HTR5A-AS1. There are currently no known drugs that target HTR5A-AS1, and it is not considered a direct therapeutic target like a receptor, enzyme, or transporter. There is also no available information indicating it is currently used as a biomarker or has noted safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HTR5A antisense RNA 1 (HTR5A-AS1).